Goodrx Holdings Inc (GDRX)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.21B
Last updated: Nov 17, 2026 at 11:05 AM ET
Goodrx Holdings Inc (GDRX) P/E Ratio & Valuation History
Goodrx Holdings (GDRX) trades at 14.6x trailing earnings and 1.5x sales. Its P/E of 14.6x is below its 5-year median of 17.5x. Its forward P/E is 10.3x. The median P/E across 8 similar companies is 35.2x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 41.7% higher over the next year. Its free cash flow yield is 11.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 14.6x |
| Forward P/E | 10.3x |
| Price to sales | 1.5x |
| Price to book | 1.8x |
| EV/EBITDA | 8.3x |
| Price to FCF | 9.0x |
| EV/FCF | 10.5x |
| PEG | N/A |
| FCF yield | 11.1% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 14.6x | 17.5x | N/A |
| P/S | 1.5x | 2.8x | N/A |
| P/B | 1.8x | 2.7x | N/A |
Valuation History
Over the 5 of the 6 year ends shown that have a P/E, its P/E ranged from 7.7x in 2025 to 99.0x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $2.71 | 7.7x | 1.2x | 1.5x |
| 2024 | $4.65 | 14.1x | 2.2x | 2.5x |
| 2023 | $6.70 | 23.9x | 3.7x | 3.5x |
| 2022 | $4.66 | 15.5x | 2.5x | 2.4x |
| 2021 | $32.68 | 99.0x | 17.9x | 16.1x |
| 2020 | $40.34 | N/A | 24.4x | 22.8x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GDRX
What is GDRX's forward P/E ratio?
Goodrx Holdings has a forward P/E ratio of 10.3x.
Is GDRX stock overvalued?
GNG's valuation label for GDRX is Undervalued. Its P/E of 14.6x compares with a median of 35.2x across 8 similar companies.
What is GDRX's price to sales ratio?
Goodrx Holdings has a price to sales ratio of 1.5x.
What is Goodrx Holdings's average P/E ratio over 5 years?
Goodrx Holdings's median P/E over the last 5 years is 17.5x, from 60 month-end values through Oct 2026.
GDRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors